Cited by 51Pharmaceutical Practices and Patient OutcomesHealthcare cost, quality, practicesChronic Disease Management Strategies

Legacy drug prescribing patterns in primary care

Open access
Mangin, Dee, Lawson, Jennifer, Cuppage, Jessica, Shaw, Elizabeth, Ivanyi, Katalin, Davis, Amie, Risdon, Cathy·2018·The Annals of Family Medicine

Abstract

PURPOSE Polypharmacy is a key clinical challenge for primary care. Drugs that should be prescribed for an intermediate term (longer than 3 months, but not indefinitely) that are not appropriately discontinued could contribute to polypharmacy. We named this type of prescribing legacy prescribing. Commonly prescribed drugs with legacy prescribing potential include antidepressants, bisphosphonates, and proton pump inhibitors (PPIs). We evaluated the proportion of legacy prescribing within these drug classes. METHODS We conducted a population-based retrospective cohort study using prospectively collected data from the McMaster University Sentinel and Information Collaboration (MUSIC) Primary Care Practice Based Research Network, located in Hamilton, Ontario. All adult patients (aged 18 or older) in the MUSIC data set during 2010-2016 were included (N = 50,813). We calculated rates of legacy prescribing of antidepressants (prescription longer than 15 months), bisphosphonates (longer than 5.5 years), and PPIs (longer than 15 months). RESULTS The proportion of patients having a legacy prescription at some time during the study period was 46% (3,766 of 8,119) for antidepressants, 14% (228 of 1,592) for bisphosphonates, and 45% (2,885 of 6,414) for PPIs. Many of these patients held current prescriptions. The mean duration of prescribing for all legacy prescriptions was significantly longer than that for non–legacy prescriptions (P <.001). Concurrent legacy prescriptions for both antidepressants and PPIs was common, signaling a potential prescribing cascade. CONCLUSIONS The phenomenon of legacy prescribing appears prevalent. These data demonstrate the potential of legacy prescribing to contribute to unnecessary polypharmacy, providing an opportunity for system-level intervention in primary care with enormous potential benefit for patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1370/afm.2315

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A Canadian primary care study of 8119 patients found that antidepressants were prescribed longer than needed, 15 months or longer with a mean duration of 4.8 years, for 46% of patients.

    “A Canadian primary care study (n = 8119) found that antidepressants were prescribed longer than needed (15 months or longer, with a mean duration of 4.8 years) for 46% of patients (Mangin 2018).”

    From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Mangin 2018

    The Abstract and Main Study Findings report that 3,766 of 8,119 patients prescribed antidepressants (46%) met the legacy-prescribing threshold of longer than 15 months; their mean prescription duration was 4.8 years. But the Strengths and Limitations section says some prescriptions meeting the criteria may have been clinically appropriate and that individual appropriateness was beyond the study’s scope. Thus the study does not establish that treatment was longer than needed for every patient in the 46%. Page numbers were not provided in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 47 · Cited by 51

Authors
Mangin, D., Lawson, J., Cuppage, J., Shaw, E., Ivanyi, K., Davis, A., & Risdon, C.
Affiliations
  • University of Otago (NZ)
  • McMaster University (CA)
  • University of Toronto (CA)
Venue
The Annals of Family Medicine
Published
2018-11
Volume
16
Issue
6
Pages
515-520
ISSN
  • 1544-1709 (ISSN-L)
  • 1544-1717
OpenAlex
W2901481540
Cited by
51
References
47
Citations by year
2026: 5 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 15 · 2020: 5 · 2019: 3 · 2018: 3
FWCI
3.60
Type
journal article
Language
en
Open access
Locations
  • The Annals of Family Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords
polypharmacy, antidepressants, bisphosphonates, proton pump inhibitors, prescription duration, prescribing cascades, primary care, drug discontinuation
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Diphosphonates, Female, Humans, Male, Middle Aged, Ontario, Practice Patterns, Physicians', Drug Prescriptions, Primary Health Care, Prospective Studies, Retrospective Studies, Prevalence, Polypharmacy, Bone Density Conservation Agents, Proton Pump Inhibitors, Young Adult, Inappropriate Prescribing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review